Signatope
Signatope is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Non-Randomized, Open-Label, Non-Controlled, Adaptive, Multiple-Dose Study To Investigate The Safety, Tolerability, And Pharmacokinetics Of Zosurabalpin Following Intravenous Administration In Healthy Participants
Sponsor Not reported
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available3 trial-level findings · Read insights
- The trial enrolled 35 healthy subjects at one investigative site in the Netherlands between 18 October 2023 and 28 March 2024.
- All subjects in the 1500 mg/Q12h cohort discontinued before Day 10, precluding Day 10 pharmacokinetic assessments for this cohort.
- A protocol amendment added ultrasound inspection at follow-up after PICC-line removal to monitor safety and well-being.
These findings describe the trial, not the service provider’s performance or responsibility.
Questions about this trial experience
What services are recorded for Signatope?
The 2026-10-09 snapshot links Signatope to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Signatope?
The most frequently recorded therapeutic areas are Other. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Signatope conducted?
The linked trials record locations in 1 country, including Netherlands. These are trial locations, not confirmed office locations or countries where Signatope delivered services.
What can this page tell me about Signatope's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Signatope. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Signatope GmbH